scholarly article | Q13442814 |
P356 | DOI | 10.4049/JIMMUNOL.1201321 |
P698 | PubMed publication ID | 23066150 |
P50 | author | Paul Whi Parren | Q38589875 |
Christian Kellner | Q51773278 | ||
P2093 | author name string | Matthias Peipp | |
Jan G J van de Winkel | |||
Thomas Valerius | |||
Martin Gramatzki | |||
Roland Repp | |||
Andreas Humpe | |||
Daniela Hallack | |||
Tina Maurer | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phenotype | Q104053 |
cytotoxicity | Q246181 | ||
P304 | page(s) | 5037-5046 | |
P577 | publication date | 2012-10-12 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity | |
P478 | volume | 189 |
Q35236076 | Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study. |
Q38129635 | B7 family checkpoint regulators in immune regulation and disease |
Q35798978 | B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape |
Q48124547 | CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells. |
Q41144481 | Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer |
Q39037081 | DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies |
Q35861726 | Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines |
Q38563897 | Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. |
Q36544773 | HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity |
Q97423740 | Mechanisms of Maintenance of Foot-and-Mouth Disease Virus Persistence Inferred From Genes Differentially Expressed in Nasopharyngeal Epithelia of Virus Carriers and Non-carriers |
Q38739764 | Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia |
Q90663890 | NK cell-mediated anti-leukemia cytotoxicity is enhanced using a NKG2D ligand MICA and anti-CD20 scfv chimeric protein |
Q26772347 | Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy |
Q58764532 | Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy |
Q93167071 | Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis |
Q43084705 | Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype |
Q48098708 | The B7 Family Member B7-H6: a New Bane of Tumor |
Q64248384 | The Natural Cytotoxicity Receptors in Health and Disease |
Q33840201 | The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells. |
Q48239951 | The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma |
Q85963384 | [The research progress of costimulatory molecule B7 family in hematological malignancy] |